XML 23 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY: (Details) (USD $)
3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 0 Months Ended 9 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Mar. 31, 2013
Dec. 31, 2013
Minimum
Dec. 31, 2012
Minimum
Dec. 31, 2013
Minimum
Dec. 31, 2012
Minimum
Dec. 31, 2013
Maximum
Dec. 31, 2012
Maximum
Dec. 31, 2013
Maximum
Dec. 31, 2012
Maximum
Aug. 29, 2011
2011 Common stock repurchase program
Dec. 31, 2013
2011 Common stock repurchase program
EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY:                              
Range of exercise prices for options and warrants (in dollars per share)           $ 32.85 $ 17.76 $ 21.46 $ 13.10 $ 62.06 $ 62.06 $ 62.06 $ 62.06    
Stockholders' Equity                              
Maximum amount of common stock that may be repurchased                           $ 250,000,000  
Shares repurchased                             2,000,000
Repurchase of treasury stock     52,663,000 65,356,000                     52,700,000
Cumulative shares repurchased                             12,300,000
Cumulative amount paid for repurchase of treasury stock 937,327,000   937,327,000   882,959,000                   192,600,000
Remaining capacity under the stock repurchase program                             57,400,000
Basic earnings per share:                              
Net earnings 15,067,000 14,449,000 38,026,000 44,020,000                      
Net gain (loss) attributable to noncontrolling interest   (76,000) (60,000) (349,000)                      
Net earnings attributable to Acxiom 15,067,000 14,525,000 38,086,000 44,369,000                      
Basic weighted-average shares outstanding 75,009,000 74,103,000 74,155,000 75,195,000                      
Net earnings (in dollars per share) $ 0.20 $ 0.19 $ 0.51 $ 0.59                      
Net earnings attributable to Acxiom (in dollars per share) $ 0.20 $ 0.20 $ 0.51 $ 0.59                      
Diluted earnings per share:                              
Basic weighted-average shares outstanding 75,009,000 74,103,000 74,155,000 75,195,000                      
Dilutive effect of common stock options, warrants, and restricted stock as computed under the treasury stock method (in shares) 2,830,000 1,775,000 2,301,000 1,792,000                      
Diluted weighted-average shares outstanding 77,839,000 75,878,000 76,456,000 76,987,000                      
Net earnings (in dollars per share) $ 0.19 $ 0.19 $ 0.50 $ 0.57                      
Net earnings attributable to Acxiom (in dollars per share) $ 0.19 $ 0.19 $ 0.50 $ 0.58                      
Stockholders' Equity                              
Outstanding options and warrants for the purchase of common stock (in shares) 6,400,000   6,400,000                        
Outstanding restricted stock units for purchase of common stock (in shares) 2,200,000   2,200,000                        
Number of shares outstanding under options, warrants and restricted stock units 549,000 4,752,000 1,400,000 7,872,000                      
Accumulated Other Comprehensive Income                              
Foreign currency translation 13,197,000   13,197,000   12,175,000                    
Unrealized loss on interest rate swap         (752,000)                    
Accumulated Other Comprehensive Income $ 13,197,000   $ 13,197,000   $ 11,423,000